About: http://data.cimple.eu/news-article/579ae1b57a5e1486eb2c7822e16209980a6ec316bf3a794c398e7de0

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/579ae1b57a5e1486eb2c7822e16209980a6ec316bf3a794c398e7de0 Goto Sponge Distinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Germany's vaccine commission on Thursday approved the AstraZeneca/Oxford Covid-19 vaccine for people over 65 following the publication of new data from the UK. "The vaccine commission now recommends the AstraZeneca vaccine for people over 65 as well. This is good news for older people who are waiting for a jab," said Health Minister Jens Spahn. Germany had previously said it lacked sufficient data to greenlight the vaccine for older people. But in an online statement, the vaccine commission said it had now revised its decision based on new data from England and Scotland, where the vaccine is already being rolled out among older people. "The data, which have only been available for a few days... provide the first robust results showing effectiveness in older people after one dose," the statement said. It added that the studies had shown the vaccine to be effective in preventing the most serious cases of the Covid-19 disease. The commission recommended that the first and second AstraZeneca jabs should be administered 12 weeks apart where possible, while people who had already been infected should receive one jab at least six months after diagnosis. Health Minister Spahn said that Germany's vaccine law would soon be changed to reflect the new recommendations. Thursday's announcement came after Chancellor Angela Merkel said Wednesday that the commission would be changing its position on the AstraZeneca jab. The German government had been criticised in recent weeks for muddled communications about the AstraZeneca jab, leading to a public perception that the vaccine was less effective than those developed by Pfizer-BioNTech and Moderna. Some of the Germans first in line for a Covid-19 jab have spurned the AstraZeneca offer, leaving the country with hundreds of thousands of unopened doses. Greenlighting the jab for the oldest age groups is expected to help Germany work through the backlog and pick up the pace of its sluggish vaccine rollout. kih/fec/pvh
schema:headline	Germany approves AstraZeneca jab for over-65s
schema:mentions	Ecliptica Jens Spahn Jab University of Oxford Angela Merkel Scotland AstraZeneca Germany England Vaccine Coronavirus disease 2019 Green-light Demography of the United Kingdom PVH (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	75 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory behaviour and mind control conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software